Drugs / Trimethoprim/Sulfamethoxazole
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2/3 | NCT00080119 Background | Feb 2004 → May 2009 | HIV infectious disease, Pneumocystis infectious disease, tuberculosis | International Maternal Pediatric Adolescent AIDS Clinical Trials Group | Terminated | Missed primary |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Trimethoprim/Sulfamethoxazole | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00080119 ↗ |
| Known as | TMP/SMX | “Trimethoprim/Sulfamethoxazole (TMP/SMX) 5 mg/kg of TMP component orally once a day” NCT00080119 ↗ |
| Route | Oral | “Trimethoprim/Sulfamethoxazole (TMP/SMX) 5 mg/kg of TMP component orally once a day” NCT00080119 ↗ |